Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
61,928,932
-
Shares change
-
+3,592,875
-
Total reported value, excl. options
-
$7,267,064,424
-
Value change
-
+$416,027,513
-
Put/Call ratio
-
66%
-
Number of buys
-
88
-
Number of sells
-
-78
-
Price
-
$117.36
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2022
210 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q1 2022.
Ascendis Pharma A/S - ADR (ASND) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61,928,932 shares
.
Largest 10 shareholders include Artisan Partners Limited Partnership (8,212,938 shares), RA CAPITAL MANAGEMENT, L.P. (7,567,900 shares), FMR LLC (5,354,756 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,870,151 shares), WELLINGTON MANAGEMENT GROUP LLP (4,665,579 shares), BAKER BROS. ADVISORS LP (4,541,604 shares), JANUS HENDERSON GROUP PLC (3,415,527 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2,635,027 shares), Avoro Capital Advisors LLC (2,200,000 shares), and GOLDMAN SACHS GROUP INC (1,754,458 shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.